More on ipha

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (9/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Innate Pharma (NQ:IPHA)
Delayed: 1.81 +0.04 (2.26%)
Prev. Close $1.77  
Open$1.78 
52 Wk High$ 
52 Wk Low$ 
Day High$1.91 
Day Low$1.78 
P/E N/A  
EPS$ 
Volume3,827 

Friends, Peers and Foes (?): IPH AUTL (more...)

Jul 23, 2026 06:06 AM Form 6-K Innate Pharma SA For: Jul 23
Jul 23, 2026 01:00 AM Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference
Jul 21, 2026 06:06 AM Form 6-K Innate Pharma SA For: Jul 21
Jul 21, 2026 01:00 AM Innate Pharma completes enrollment in Phase 1 IPH4502 ADC study
Jul 21, 2026 01:00 AM Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)
Jun 22, 2026 08:00 AM Form SCHEDULE 13G/A Innate Pharma SA Filed by: NOVO NORDISK A S
May 22, 2026 06:03 AM Form 6-K Innate Pharma SA For: May 22
May 22, 2026 01:00 AM Outcome of Innate Pharma’s 2026 Annual General Meeting
May 19, 2026 06:05 AM Form 6-K Innate Pharma SA For: May 19
May 19, 2026 01:01 AM Innate Pharma to participate in the Jefferies Global Healthcare Conference
View All Articles

Entities mentioned with ipha

View All Entities